These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Refining the use of warfarin through genetic testing. Lee SC Int Angiol; 2008 Aug; 27(4):271-3. PubMed ID: 18677287 [No Abstract] [Full Text] [Related]
3. Pharmacogenomic testing for warfarin dosing: we are ready now. Wu AH Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1483-5. PubMed ID: 19954308 [No Abstract] [Full Text] [Related]
4. The long and winding road to warfarin pharmacogenetic testing. Ginsburg GS; Voora D J Am Coll Cardiol; 2010 Jun; 55(25):2813-5. PubMed ID: 20579536 [No Abstract] [Full Text] [Related]
5. Warfarin and pharmacogenomic testing: what would Pascal do? Teagarden JR Pharmacotherapy; 2009 Mar; 29(3):245-7. PubMed ID: 19249943 [No Abstract] [Full Text] [Related]
6. Genetic testing for warfarin dosing? Not yet ready for prime time. Bussey HI; Wittkowsky AK; Hylek EM; Walker MB Pharmacotherapy; 2008 Feb; 28(2):141-3. PubMed ID: 18225960 [No Abstract] [Full Text] [Related]
7. Pharmacogenetic-based dosing of warfarin. Med Lett Drugs Ther; 2008 May; 50(1286):39-40. PubMed ID: 18487958 [No Abstract] [Full Text] [Related]
8. Dynamic pharmacogenetic models in anticoagulation therapy. Bon Homme M; Reynolds KK; Valdes R; Linder MW Clin Lab Med; 2008 Dec; 28(4):539-52. PubMed ID: 19059061 [TBL] [Abstract][Full Text] [Related]
9. Role of warfarin pharmacogenetic testing in clinical practice. Tan GM; Wu E; Lam YY; Yan BP Pharmacogenomics; 2010 Mar; 11(3):439-48. PubMed ID: 20402581 [TBL] [Abstract][Full Text] [Related]
12. Should we be applying warfarin pharmacogenetics to clinical practice? No, not now. Rosove MH; Grody WW Ann Intern Med; 2009 Aug; 151(4):270-3, W95. PubMed ID: 19687493 [TBL] [Abstract][Full Text] [Related]
13. Genetic help for a blood-thinner balancing act? There's little evidence yet that a genetic test improves the safety of warfarin. Harv Heart Lett; 2007 Dec; 18(4):1-2. PubMed ID: 18219801 [No Abstract] [Full Text] [Related]
14. Using pharmacogenetics in real time to guide warfarin initiation: a clinician update. Carlquist JF; Anderson JL Circulation; 2011 Dec; 124(23):2554-9. PubMed ID: 22144632 [No Abstract] [Full Text] [Related]
15. Warfarin dose requirement for patients with both VKORC1 3673A/A and CYP2C9*3/*3 genotypes. Fukuda T; Tanabe T; Ohno M; Tougou K; Fujio Y; Azuma J; Yamamoto I; Takeda A Clin Pharmacol Ther; 2006 Nov; 80(5):553-4. PubMed ID: 17112813 [No Abstract] [Full Text] [Related]